I don’t suppose you’ve seen those two boiled eggs I left sitting on the kitchen sideboard by any chance? pic.twitter.com/dV2YSbZL6R
— Stevie K (@1StevieKilner) February 17, 2019
“I’m a bird dog, retrieving some… pre-born birds!”
Also, bad news for Peter ‘Bathory’ Thiel, from Bloomberg:
Taking a young person’s plasma and infusing it into an older person to ward off aging — a therapy that’s fascinated some of the biggest names in Silicon Valley — has no proven clinical benefit, the Food and Drug Administration said.
The agency issued a safety alert on Tuesday about the infusion of plasma from young donors for the prevention of conditions such as aging or memory loss, or for the treatment of such conditions as dementia, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease or post‐traumatic stress disorder…
Ambrosia’s website was updated Tuesday to say it has “ceased patient treatments” in compliance with the FDA’s advisory…
… Plasma infusion is an approved use by the FDA in trauma settings or in patients whose blood doesn’t coagulate. But, the FDA says, there are risks, including allergic reactions, circulatory overload, lung injury and infectious disease transmission.
“We’re concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies,” Gottlieb and Marks said. “Such treatments have no proven clinical benefits for the uses for which these clinics are advertising them, and are potentially harmful.”